Fade Dark Spots, Even Skin Tone.

NanoMD® Cyntra™ 2.0 is a next-generation brightening cream powered by 8% cysteamine and tranexamic acid. Clinically developed to target melasma, hyperpigmentation, and stubborn dark patches with superior precision and improved tolerability.

Kick Start Your Glow

NanoMD® Cyntra™ 2.0 interrupts melanin production at multiple stages for faster, more consistent brightening. With Carrier-Effect™ delivery and Smart Matrix soothing technology, it makes powerful ingredients comfortable enough for daily use — even on sensitive skin.

Rapid Onset

Enhance Skin Tone

Superior Absorption

Slow Down Skin Aging

How NanoMD® Cyntra™ 2.0 Improves Skin Clarity

Cysteamine

Cyntra™ combines two powerhouse brightening actives to rebalance pigmentation safely and effectively.

Cysteamine (8%) — The Gold Standard
Cysteamine is a naturally occurring molecule in human cells. At therapeutic strength, it helps reduce the appearance of melasma and dark spots by regulating overactive pigment production at its biochemical source.

Tranexamic Acid — The Calm Behind the Clarity
This ingredient works by interrupting inflammatory and vascular signals that trigger stubborn pigmentation, helping prevent recurrence and supporting a more even tone. Together, they deliver a dual-action depigmenting effect proven to outperform conventional brightening creams.

After 1 Month of Cyntra

After 1 Month of Lumithion

Brighter, more even skin

Noticeably lighter dark patches

Improved overall skin-tone

Clinically proven to improve skin tone in 8 weeks

The Breakthrough: Smart Nanodelivery You Can Feel Working

Traditional creams struggle to penetrate the skin’s barrier. Cyntra™ changes that.

Carrier-Effect™ Nanodelivery
Ensures actives reach deeper layers where melanin is actually produced, improving speed and consistency of results.

Smart Matrix Technology
A soothing system designed to reduce irritation, minimise redness, and make daily usage comfortable — even at clinical-strength 8% cysteamine.
Contact Us

Why Choose NanoMD® Cyntra™

NanoMD® CYNTRA™ uses advanced nanoencapsulation technology to deliver cysteamine and tranexamic acid (TXA) together — exactly where they’re needed in the skin.

 Cysteamine is a well-studied, high-safety molecule naturally found in human cells. It helps reduce existing pigmentation and slows the formation of new dark spots.
 Tranexamic acid, an amino-acid derivative, works by calming the inflammatory and vascular signals that trigger melasma and excess pigment production.

 When these two ingredients are delivered simultaneously in nano-sized carriers, TXA enhances the brightening power of cysteamine by slowing down the activity and growth of melanocytes — the cells responsible for producing pigment.

Formula-stabilizing nano-encapsulation

Preserves ingredient potency, boosts skin penetration and reduces irritation for enhanced efficacy and comfort.

Carrier Effect™

The synergy of surface charge control and enzyme-drive release, guides actives deeper and releases them precisely when needed.

Smart Matrix

Forms a gel-like film that stabilizes actives, prolongs their contact and release, and soothes the skin.

Aspartame and Sugar-Free

No animal-derived ingredients - Suitable for diabetics and vegetarian.
Get Product

Apply a thin layer once daily, or as directed by your clinic.

For best results:

  • Use consistently for 8–12 weeks
  • Follow with a gentle moisturiser if needed
  • Use high-SPF sunscreen daily to maintain progress

Clinics often pair Cyntra™ with NanoMD® Lumithion™ for enhanced inside-out brightness.

Frequently Asked Questions 

This section addresses any question about Lumithion. If you have more question, we’re always ready to help you out.
Contact Us

Ready to Experience Bright Skin Backed by Science?

Rebuild your skin from within with biotech formulations trusted by medical professionals and loved by patients.
Contact Us

References

  1. Khatri, Khalil A., et al. (2024). Efficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma. Journal of Drugs in Dermatology (JDD), 23(7), 529–537.
  2. Atallah, Carla, et al. (2022). Effect of cysteamine hydrochloride-loaded liposomes on skin depigmenting and penetration. European Journal of Pharmaceutical Sciences, 168, 106082.

Fade Melasma From Within.

NanoMD® addresses the root triggers of melasma—hormones, inflammation, and oxidative stress—with physician-guided solutions that work beneath the skin’s surface.

Our Solutions

LumithionCyntra